Country

Merz North America Promotes Alana Sine to Chief Financial Officer

Merz North America today announced the appointment of Alana Sine to Chief Financial Officer (CFO), Merz North America. Sine has served as interim CFO since March 2018.

“Our exhaustive global search for a chief financial officer who can help us continue our rapid growth led us right back to Raleigh,” said Bob Rhatigan, CEO of Merz North America. “Alana has a unique combination of deep industry experience and strong finance credentials. Her professionalism and effectiveness as interim CFO over the past four months made it clear that she’s the right person to help us achieve our goal of becoming the most admired, trusted and innovative aesthetics and neurotoxin company. As Merz continues to evolve and invest in talent development, we are proud to celebrate Alana’s career progression during her time with the company and look forward to her contributions and leadership in her new role as CFO.“

Sine will lead the finance function for North America, overseeing financial reporting, governance, strategic planning, tax & treasury and collaboration with Merz’s global headquarters in Frankfurt, Germany, on financial matters. She will report to Rhatigan and join the North America Leadership Team (NALT).

“I’ve dedicated a good portion of my career to Merz North America because what we do here matters – we have a positive impact on patients’ lives,” Sine said. “I’m honored and excited to join a leadership team that is driving us to new levels of performance.”

Over the course of her 13-year tenure at Merz North America, Sine assumed finance roles of increasing responsibility, including tax and financial reporting. As interim CFO, she successfully led the budget and strategic planning process for the coming fiscal year. Prior to joining Merz, Sine held accounting and finance roles at Ernst & Young (now EY) and Lowe’s Food Stores. She earned undergraduate and graduate degrees in accounting from the University of North Carolina – Greensboro and is a certified public accountant (CPA) in the state of North Carolina.

Press Contact

Jane Yarbrough
Corporate Communications
Merz Therapeutics
Merz Pharmaceuticals, LLC
6601 Six Forks Road, Suite 430
Raleigh, NC 27615

 

(984) 218-0983
Jane.Yarbrough@merz.com


Merz Therapeutics

At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life. With our patient-centric approach, cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards, including botulinum toxin. Merz Therapeutics, a business of Merz Pharmaceuticals GmbH, is headquartered in Frankfurt, Germany and is represented in more than 90 countries, with a North America affiliate based in Raleigh, North Carolina. Merz Pharmaceuticals GmbH is part of the Merz Group, a privately held, family-owned company that has dedicated more than 110 years to developing innovations that serve unmet patient and customer needs.